Colistin Interaction and Surface Changes Associated with mcr-1 Conferred Plasmid Mediated Resistance in E. coli and

Firdoos Ahmad Gogry1, Mohammad Tahir Siddiqui1, Insha Sultan1

  • 1Department of Biosciences, Jamia Millia Islamia, New Delhi 110025, India.

Pharmaceutics
|February 26, 2022
PubMed

Insights

Colistin resistance in bacteria like E. coli involves blocking its electrostatic interaction with bacterial membranes. This study shows resistant strains prevent colistin binding, hindering its antibacterial action.

Area of Science:

  • Microbiology
  • Biochemistry
  • Drug Resistance

Background:

  • Colistin is a last-resort antibiotic for carbapenem-resistant Gram-negative bacterial infections.
  • Its mechanism involves electrostatic interaction between the cationic peptide and anionic lipid A in bacterial membranes.

Purpose of the Study:

  • To investigate the interaction of colistin with outer membranes of susceptible and resistant E. coli and A. veronii strains.
  • To elucidate the molecular mechanisms underlying colistin resistance.

Main Methods:

  • Bacterial membrane and lipopolysaccharide isolation.
  • Deoxycholate and lysozyme sensitivity tests.
  • N-phenyl-1-naphthylamine (NPN) uptake assay.
  • Atomic force microscopy (AFM).
  • Zeta potential measurements.
  • 1H NMR analysis.

Main Results:

  • Colistin binding affinity was lower with resistant bacterial outer membranes.
  • Resistant strains showed reduced outer membrane permeability to colistin.
  • AFM revealed smoother, deformed membranes in susceptible cells vs. rougher topography in resistant cells.
  • Zeta potential indicated altered surface charges in resistant strains.
  • NMR showed no line broadening in resistant strains, unlike susceptible ones.

Conclusions:

  • Resistant E. coli and A. veronii strains impede colistin's electrostatic binding to lipid A.
  • This blockage prevents colistin's membrane permeabilization and antibacterial activity.
  • Understanding these resistance mechanisms is crucial for developing new antimicrobial strategies.